Overview

Anti-inflammatory Effects of Tiotropium in Patients With Stable COPD

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study aims to assess the anti-inflammatory effects after 6 weeks treatment with tiotropium compared to placebo in patients with stable COPD
Phase:
Phase 4
Details
Lead Sponsor:
University Medical Center Groningen
Collaborator:
Boehringer Ingelheim
Treatments:
Anti-Inflammatory Agents
Bromides
Tiotropium Bromide